| |
|
|
BIBLIOGRAFÍA
- Ferri, C, Bellini, C, Piccoli, A, et al. Enhanced blood pressure
response to cyclooxygenase inhibition in salt-sensitive human
hypertension. Hypertension 1993; 21:875.
- Oates, JA, FitzGerald, GA, Branch, RA, et al. Clinical implications
of prostaglandin and thromboxane A2 formation (2). N Engl J
Med 1988; 319:761.
- Patrono, C, Dunn, MJ. The clinical significance of inhibition
of renal prostaglandin synthesis. Kidney Int 1987; 32:1.
- Pope, JE, Anderson, JJ, Felson, DT. A meta-analysis of the
effects of nonsteroidal anti-inflammatory drugs on blood pressure.
Arch Intern Med 1993; 153:477.
- Johnson, AG, Nguyen, TV, Owe-Young, R. Potential mechanisms
by which nonsteroidal anti-inflammatory drugs elevate blood
pressure: The role of endothelin-1. J Hum Hypertens 1996; 10:257.
- Curhan, GC, Willett, WC, Rosner, B, Stampfer, MJ. Frequency
of analgesic use and risk of hypertension in younger women.
Arch Intern Med 2002; 162:2204
- Dedier, J, Stampfer, MJ, Hankinson, SE, et al. Nonnarcotic
analgesic use and the risk of hypertension in US women. Hypertension
2002; 40:604.
- Radford MG, Holley KE, Grane JP, et al. Reversible membranous
nephropathy associated with the use of nonsteroideal anti-inflammatory
drugs. JAMA 1996; 276:466.
- Casado C, Pregado S. Patología de la retina. Manifestaciones
retinianas de la Hipertensión y la arterioesclerosis.
|
|
|
